2017 Speaking Faculty



John H. Brooks
John H. Brooks, JD, MBA
Senior Advisor to the Secretary for Drug Pricing Reform
U.S. Department of Health and Human Services (HHS)


Anna Chorniy
Anna Chorniy, PhD
Research Assistant Professor, Department of Medical Social Sciences, Buehler Center for Health Policy & Economics, Feinberg School of Medicine
Northwestern University


Saiza Elayda
Saiza Elayda, JD
Director, State Policy
PHRMA


Mark Erwin
Mark Erwin
Vice President, Market Access
Fresenius Kabi


Amanda Forys
Amanda Forys
Senior Director, Policy, Pricing, and Reimbursement
United Therapeutics Corporation


Timothy E. Hermes
Timothy E. Hermes
Vice President Market Access
Aurinia Pharamceuticals


Analise Johnian
Analise Johnian
Corporate Counsel
Sanofi


Mike Mason
Mike Mason
Vice President, Lilly Diabetes, Senior Vice President, Connected Care and Insulins
Eli Lilly and Company


Jeff Myers
Jeff Myers
Former President and CEO, Medicaid Health Plans of America; Former EVP, strategy and External Relations
CareSource


Mallory O'Connor
Mallory O'Connor
Director, Public Policy
Mallinckrodt Pharmaceuticals


Stephen Perkins
Stephen Perkins
Chief Medical Officer
UPMC Health Plan


Rob Philo
Rob Philo
Vice President, Market Access
Veloxis Pharmaceuticals


Kelly Pitt
Kelly Pitt
Director, Legal and Compliance
Sobi North America


Robert Popovian
Robert Popovian
Vice President, US Government Relations
Pfizer


Matt Portch
Matt Portch
Vice President, Sales and Market Access
Sunovion


Stella K. Vnook
Stella K. Vnook
Chief Executive Officer
Diverse Biotech


Debbie Walters
Debbie Walters
Assistant Vice President, General Counsel
Pfizer